Multi-centered open-label, observational study of Sitagliptin in West Tokyo Area

Multi-centered open-label, observational study of Sitagliptin in West Tokyo Area - Sitagliptin add-on to SU study in West Tokyo.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003362

Enrollment

100

Registered

2010-04-01

Start date

2010-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes patients. Diet and exercise only or with oral diabetic agents.

Exclusion criteria

Exclusion criteria: Renal dysfunction ;Creatinin equal or more than 2.0 mg/dl

Design outcomes

Primary

Measure	Time frame
Change of HbA1c (%) and body weight.	—

Countries

Japan

Contacts

Public ContactTakaichi Miyakawa, Yuko Watanabe, Hitomi Fujii

Tama-center Mirai Clinic Internal Medicine

042-316-8570

Outcome results